Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 13, Issue 1 pp 411—423
The improved anticancer effects of Bortezomib-loaded hollow mesoporous silica nanospheres on lymphoma development
Figure 5. The mRNA levels of Src homology 1 domain-containing protein tyrosine phosphatase (SHP-1), c-Kit, nuclear factor-κB (NF-κB), and JAK1 in SNK-1 cells treated with PBS (control), HMSNs, BTZ (75 nM), BTZ@HMSNs (containing 75 nM of BTZ) by RT-PCR. BTZ, bortezomib; HMSNs, hollow mesoporous silica nanospheres. The differences between groups were analyzed by one-way ANOVA followed by multiple comparison with Tukey test. *P < 0.05 and **P < 0.01. Values are means ± SD.